Recent trends in machine learning and deep learning-based prediction of G-protein coupled receptor-ligand binding...

Accurately predicting protein-ligand binding affinity is key in drug discovery. Machine Learning and Deep Learning methods used in the drug discovery process have advanced the prediction of drug-target binding affinities, particularly for G protein-coupled receptors (GPCRs), a pharmacologically significant yet structurally heterogeneous protein family. In this review, binding affinity prediction models are examined and organized according to sequence-based one-dimensional, graph-based two-dimensional, and structure-based three-dimensional frameworks. Sequence-based models utilize convolutional neural networks for high-throughput screening. Recently published models incorporated attention mechanisms and self-supervised learning, enhancing interpretability and reducing dependence on annotated datasets. Graph-based models employ graph neural networks and molecular contact maps to capture topological features, enabling substructure-sensitive predictions. Structure-based approaches integrate spatial and conformational data into high-resolution interaction models. The hybrid use of these three approaches could significantly increase the success rate of in silico models for drug discovery, particularly for GPCRs.